176 related articles for article (PubMed ID: 8282081)
1. Neurotrophic factors in the treatment of motor neuron disease and trauma.
DiStefano PS
Exp Neurol; 1993 Nov; 124(1):56-9. PubMed ID: 8282081
[No Abstract] [Full Text] [Related]
2. The use of trophic factors in degenerative motoneuron diseases.
Yan Q; Miller JA
Exp Neurol; 1993 Nov; 124(1):60-3. PubMed ID: 8282082
[No Abstract] [Full Text] [Related]
3. Use of growth factors in the treatment of motor neuron diseases.
Windebank AJ
Adv Neurol; 1995; 68():229-34. PubMed ID: 8787234
[No Abstract] [Full Text] [Related]
4. Neurotrophic factors as therapeutic agents in amyotrophic lateral sclerosis. Potential and pitfalls.
Henderson CE
Adv Neurol; 1995; 68():235-40. PubMed ID: 8787235
[No Abstract] [Full Text] [Related]
5. [Neurotrophic factor treatment in amyotrophic lateral sclerosis].
Tsuzaka K; Mitsumoto H
No To Shinkei; 1998 Jul; 50(7):625-30. PubMed ID: 9739520
[No Abstract] [Full Text] [Related]
6. Will ciliary neurotrophic factor slow progression of motor neuron disease?
Longo FM
Ann Neurol; 1994 Aug; 36(2):125-7. PubMed ID: 8053646
[No Abstract] [Full Text] [Related]
7. Trophic support of motoneurons: physiological, pathophysiological, and therapeutic implications.
Thoenen H; Hughes RA; Sendtner M
Exp Neurol; 1993 Nov; 124(1):47-55. PubMed ID: 8282079
[No Abstract] [Full Text] [Related]
8. Neuron saving schemes.
Lindsay RM
Nature; 1995 Jan; 373(6512):289-90. PubMed ID: 7830762
[No Abstract] [Full Text] [Related]
9. [Neurotrophic factors. Therapeutic approach in neurodegenerative diseases].
Wasielewski S
Med Monatsschr Pharm; 1992 Apr; 15(4):98-9. PubMed ID: 1584114
[No Abstract] [Full Text] [Related]
10. Insulin-like growth factor-I: potential for treatment of motor neuronal disorders.
Lewis ME; Neff NT; Contreras PC; Stong DB; Oppenheim RW; Grebow PE; Vaught JL
Exp Neurol; 1993 Nov; 124(1):73-88. PubMed ID: 8282084
[TBL] [Abstract][Full Text] [Related]
11. Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Murray SS; Piccenna LG; Lopes EC; Kilpatrick TJ; Cheema SS
J Neurosci Res; 2004 Oct; 78(2):193-9. PubMed ID: 15378612
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophic factors and amyotrophic lateral sclerosis.
Askanas V
Adv Neurol; 1995; 68():241-4. PubMed ID: 8787236
[No Abstract] [Full Text] [Related]
13. On the therapeutic potential for insulin-like growth factor use in motor neuron disease.
Ishii DN; Marsh DJ
Exp Neurol; 1993 Nov; 124(1):96-9. PubMed ID: 8282086
[No Abstract] [Full Text] [Related]
14. Can neurotrophic factors prevent or reverse motoneuron injury in amyotrophic lateral sclerosis?
Appel SH; Smith RG
Exp Neurol; 1993 Nov; 124(1):100-2. PubMed ID: 8282067
[No Abstract] [Full Text] [Related]
15. Genetic variation in the ciliary neurotrophic factor receptor alpha gene and familial amyotrophic lateral sclerosis.
Imura T; Shimohama S; Kawamata J; Kimura J
Ann Neurol; 1998 Feb; 43(2):275. PubMed ID: 9485075
[No Abstract] [Full Text] [Related]
16. Ciliary neurotrophic factor as a motor neuron trophic factor.
Kuzis K; Eckenstein FP
Perspect Dev Neurobiol; 1996; 4(1):65-74. PubMed ID: 9169920
[TBL] [Abstract][Full Text] [Related]
17. [Amyotrophic lateral sclerosis].
Moriwaka F
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):21-5. PubMed ID: 9086359
[TBL] [Abstract][Full Text] [Related]
18. Experimental rationale for the therapeutic use of neurotrophins in amyotrophic lateral sclerosis.
Seeburger JL; Springer JE
Exp Neurol; 1993 Nov; 124(1):64-72. PubMed ID: 8282083
[TBL] [Abstract][Full Text] [Related]
19. Lay-offs follow suspension of clinical trials of protein.
Verrall M
Nature; 1994 Jul; 370(6484):6. PubMed ID: 8015607
[No Abstract] [Full Text] [Related]
20. Therapeutic horizons for amyotrophic lateral sclerosis.
Rothstein JD
Curr Opin Neurobiol; 1996 Oct; 6(5):679-87. PubMed ID: 8937834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
